iBio Inc (IBIO)

Healthcare | Biotechnology
Income Statement (Quarterly) 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue 0 200,000 0 175,000
Cost of Revenue 0 0 0 -744,000
Gross Profit 0 200,000 0 919,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,973,000 2,742,000 2,801,000 2,444,000
Operating Expenses 4,879,000 4,619,000 4,106,000 3,584,000
Operating Income -4,879,000 -4,419,000 -4,106,000 -3,409,000
Interest Expense 54,000 57,000 57,000 60,000
Income Before Tax -4,861,000 -4,364,000 -3,989,000 -3,246,000
Income Tax Expense 0 0 0 0
Net Income -4,861,000 -4,364,000 -3,989,000 -7,778,000
Per Share
EPS -0.49 -0.48 -0.46 -0.90
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Revenue 400,000 225,000 0 2,383,000 2,371,000
Cost of Revenue 0 1,250,000 1,106,000 216,000 1,462,000
Gross Profit 0 225,000 -1,106,000 2,167,000 909,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 10,690,000 11,674,000 18,451,000 34,128,000 22,031,000
Operating Expenses 19,002,000 16,859,000 29,343,000 51,857,000 32,020,000
Operating Income -18,377,000 -16,634,000 -29,311,000 -49,690,000 -31,111,000
Interest Expense -212,000 172,000 0 1,412,000 2,454,000
Income Before Tax 0 -15,443,000 -29,311,000 -50,304,000 -23,213,000
Income Tax Expense 0 0 -1,639,000 701,000 0
Net Income 0 -24,907,000 -29,311,000 -51,005,000 -23,207,000
Per Share
EPS -1.75 -6.50 -23.94 -2,924.26 -2.97
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Cash and Cash Equivalents 8,582,000 14,210,000 4,301,000 22,676,000
Short Term Investments 0 0 0 10,845,000
Net Receivables 0 713,000 204,000 6,100,000
Inventory 0 0 21,090,000 3,900,000
Total Current Assets 9,721,000 15,672,000 26,259,000 45,070,000
Property Plant Equipment 5,282,000 6,372,000 7,551,000 41,755,000
Goodwill and Intangibles 6,848,000 5,368,000 5,388,000 4,851,000
Total Assets 23,185,000 28,734,000 41,207,000 99,406,000
Liabilities
Account Payables 2,188,000 358,000 1,849,000 4,264,000
Short Term Debt 543,000 953,000 13,598,000 22,308,000
Total Current Liabilities 6,106,000 3,840,000 21,582,000 30,436,000
Long Term Debt 2,199,000 3,507,000 3,476,000 5,485,000
Total Liabilities 8,305,000 7,410,000 25,826,000 35,921,000
Shareholders Equity
Retained Earnings -332,224,000 -313,847,000 -288,940,000 -223,930,000
Total Shareholders Equity 14,880,000 21,324,000 15,381,000 63,485,000
Balance Sheet (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Assets
Cash and Cash Equivalents 8,582,000 14,210,000 4,301,000 22,676,000 77,404,000
Short Term Investments 0 0 0 10,845,000 19,570,000
Net Receivables 0 713,000 204,000 6,100,000 5,526,000
Inventory 0 0 21,090,000 3,900,000 27,000
Total Current Assets 9,721,000 15,672,000 26,259,000 45,070,000 104,597,000
Property Plant Equipment 5,282,000 6,372,000 7,551,000 41,755,000 34,739,000
Goodwill and Intangibles 6,848,000 5,368,000 5,388,000 4,851,000 952,000
Total Assets 23,185,000 28,734,000 41,207,000 99,406,000 146,968,000
Liabilities
Account Payables 2,188,000 358,000 1,849,000 4,264,000 2,254,000
Short Term Debt 543,000 953,000 13,598,000 22,308,000 967,000
Total Current Liabilities 6,106,000 3,840,000 21,582,000 30,436,000 6,645,000
Long Term Debt 2,199,000 3,507,000 3,476,000 5,485,000 31,755,000
Total Liabilities 8,305,000 7,410,000 25,826,000 35,921,000 38,400,000
Shareholders Equity
Retained Earnings -332,224,000 -313,847,000 -288,940,000 -223,930,000 -173,627,000
Total Shareholders Equity 14,880,000 21,324,000 15,381,000 63,485,000 108,585,000
Cash Flow Statement (Quarterly) 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Activities
Net Income -18,377,000 -24,907,000 -65,010,000 -50,304,000
Depreciation & Amortization 291,000 1,250,000 1,380,000 3,791,000
Stock Based Compensation 1,530,000 2,038,000 4,391,000 4,377,000
Change in Working Capital 0 -3,168,000 5,869,000 3,243,000
Operating Cash Flow -15,304,000 -18,554,000 -30,436,000 -37,480,000
Investing Activities
Capital Expenditure -16,000 -210,000 -5,738,000 -11,630,000
Investments -16,000 -210,000 -5,738,000 -11,630,000
Investing Cash Flow 742,000 906,000 7,009,000 -5,127,000
Financing Activities
Debt Repayment 0 -1,138,000 -9,625,000 -5,830,000
Common Stock Issued/Repurchased 3,541,000 25,516,000 11,448,000 77,000
Dividends Paid 0 0 0 0
Financing Cash Flow 8,929,000 24,494,000 2,301,000 -6,125,000
Summary
Free Cash Flow -15,320,000 -18,764,000 -36,174,000 -49,110,000
Net Change in Cash -5,633,000 6,846,000 -21,093,000 -48,732,000
Cash Flow Statement (Annual) 2025-06-30 2024-06-30 2023-06-30 2022-06-30 2021-06-30
Operating Activities
Net Income -18,377,000 -24,907,000 -65,010,000 -50,304,000 -23,207,000
Depreciation & Amortization 291,000 1,250,000 1,380,000 3,791,000 2,414,000
Stock Based Compensation 1,530,000 2,038,000 4,391,000 4,377,000 1,586,000
Change in Working Capital 0 -3,168,000 5,869,000 3,243,000 -11,154,000
Operating Cash Flow -15,304,000 -18,554,000 -30,436,000 -37,480,000 -30,064,000
Investing Activities
Capital Expenditure -16,000 -210,000 -5,738,000 -11,630,000 -5,162,000
Investments -16,000 -210,000 -5,738,000 -11,630,000 -4,920,000
Investing Cash Flow 742,000 906,000 7,009,000 -5,127,000 -26,478,000
Financing Activities
Debt Repayment 0 -1,138,000 -9,625,000 -5,830,000 -331,000
Common Stock Issued/Repurchased 3,541,000 25,516,000 11,448,000 77,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow 8,929,000 24,494,000 2,301,000 -6,125,000 78,835,000
Summary
Free Cash Flow -15,320,000 -18,764,000 -36,174,000 -49,110,000 -35,226,000
Net Change in Cash -5,633,000 6,846,000 -21,093,000 -48,732,000 22,292,000